Harrison G J, Willis R J, Headrick J P
Rotary Centre for Cardiovascular Research, School of Health Sciences, QLD, Australia.
Cardiovasc Res. 1998 Oct;40(1):74-87. doi: 10.1016/s0008-6363(98)00123-0.
Microdialysis and 31P-NMR spectroscopy were used to test opposing hypotheses that ischemic preconditioning inhibits adenine nucleotide degradation and purine efflux, or that preconditioning activates cardiovascular adenosine formation to provide enhanced cardioprotection.
31P-NMR spectra and matching interstitial fluid (ISF) or venous effluent samples were obtained from Langendorff perfused rat hearts. Control hearts (n = 9) underwent 30 min of global normothermic ischemia and 30 min reperfusion. Preconditioned hearts (n = 6) were subjected to a 5 min ischemic episode and 10 min reflow prior to 30 min ischemia and 30 min reperfusion. Effects of repetitive ischemia-reperfusion (3 x 5 min ischemic episodes) on adenosine levels and energy metabolism were also assessed (n = 8).
Preconditioning improved post-ischemic recovery of heart rate x left ventricular developed pressure (71 +/- 5 vs 43 +/- 8%, P < 0.05) and end-diastolic pressure (14 +/- 3 vs 29 +/- 4 mmHg, P < 0.05) compared with control hearts, respectively. Preconditioning did not alter intracellular ATP, phosphocreatine (PCr), inorganic phosphate (Pi), H+ or free Mg2+ during global ischemia, but improved recoveries of PCr, Pi, and delta GATP on reperfusion. ISF adenosine increased more than 20-fold during 30 min ischemia. The 5 min preconditioning episode increased ISF adenosine 3-fold, and reduced ISF adenosine and inosine during subsequent prolonged ischemia by up to 75%. Venous purine levels during reperfusion were also reduced by preconditioning. Accumulation of adenosine in ISF and venous effluent during repetitive ischemia was progressively reduced despite comparable changes in substrate for adenosine formation via 5'-nucleotidase, (5'-AMP), and in allosteric modulators of this enzyme (Mg2+, H+, Pi, ADP, ATP).
(i) Ischemic preconditioning reduces interstitial and vascular adenosine levels during ischemia-reperfusion, (ii) reduced ISF adenosine during ischemia is not due to reduced ischemic depletion of adenine nucleotides in preconditioned rat hearts, (iii) preconditioning may inhibit adenosine formation via 5'-nucleotidase in ischemic rat hearts, and (iv) improved functional recovery with preconditioning is unrelated to metabolic/bioenergetic changes during the ischemic insult, but may be related to improved post-ischemic recovery of [Pi] and delta GATP in this model.
采用微透析和31P-核磁共振波谱法来验证两个相反的假说,即缺血预处理可抑制腺嘌呤核苷酸降解和嘌呤流出,或者预处理可激活心血管腺苷生成以增强心脏保护作用。
从Langendorff灌注的大鼠心脏获取31P-核磁共振波谱以及匹配的间质液(ISF)或静脉流出液样本。对照心脏(n = 9)经历30分钟的整体常温缺血和30分钟再灌注。预处理心脏(n = 6)在30分钟缺血和30分钟再灌注之前先经历5分钟缺血期和10分钟再灌注。还评估了重复缺血-再灌注(3次5分钟缺血期)对腺苷水平和能量代谢的影响(n = 8)。
与对照心脏相比,预处理分别改善了缺血后心率×左心室舒张末压的恢复情况(71±5对43±8%,P<0.05)和舒张末压(14±3对29±4 mmHg,P<0.05)。预处理在整体缺血期间未改变细胞内三磷酸腺苷(ATP)、磷酸肌酸(PCr)、无机磷酸盐(Pi)、氢离子(H+)或游离镁离子(Mg2+),但改善了再灌注时PCr、Pi和ATP生成自由能(ΔGATP)的恢复情况。在30分钟缺血期间,ISF腺苷增加了20多倍。5分钟预处理期使ISF腺苷增加了3倍,并在随后的长时间缺血期间使ISF腺苷和肌苷减少了多达75%。预处理还降低了再灌注期间静脉嘌呤水平。尽管通过5'-核苷酸酶(5'-AMP)生成腺苷的底物以及该酶的变构调节剂(Mg2+、H+、Pi、二磷酸腺苷(ADP)、ATP)发生了类似变化,但在重复缺血期间ISF和静脉流出液中腺苷的积累逐渐减少。
(i)缺血预处理可降低缺血-再灌注期间的间质和血管腺苷水平;(ii)缺血期间ISF腺苷减少并非由于预处理大鼠心脏中腺嘌呤核苷酸缺血消耗减少;(iii)预处理可能通过抑制缺血大鼠心脏中5'-核苷酸酶介导的腺苷生成;(iv)预处理改善功能恢复与缺血损伤期间的代谢/生物能量变化无关,但可能与该模型中缺血后Pi和ΔGATP的恢复改善有关。